Cite
MLA Citation
Karim Amrane et al.. “First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study.” Cancer medicine, vol. 9, 2020, pp. 2309–2316. http://access.bl.uk/ark:/81055/vdc_100103423793.0x000004